Navigation Links
Bayer and Onyx Begin Enrollment in Phase 3 Trial of Nexavar in Combination With Chemotherapy Agent Capecitabine for Patients With Advanced Breast Cancer
Date:2/24/2011

news release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer's public reports which are available on the Bayer Web site at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.

This news release contains "forward-looking statements" of Onyx within the meaning of the federal securities laws. These forward-looking statements include without limitation, statements regarding the progress and results of the clinical development, safety, regulatory processes, commercialization efforts or commercial potential of Nexavar. These statements are subject to risks and uncertainties that could cause actual results and events to differ materially from those anticipated, including risks related to the development and commercialization of pharmaceutical products. Any statements contained in this press release that are not statements of historical fact may be deemed to be forward-looking statements. Reference should be made to Onyx's Annual Report on Form 10-K for the year ended December 31, 2010, filed with the Securities and Exchange Commission under the heading "Risk Factors" and Onyx's Quarterly Reports on Form 10-Q for a more detailed description of such factors. Readers are cautioned not to place undue reliance on these forward-looking statements that speak only as of the date of this release. Onyx undertakes no obligation to update publicly any forward-looking statements to reflect new information, events, or circumstances after the date of this release except as required by law.'/>"/>

SOURCE Onyx Pharmaceuticals, Inc.; Bayer HealthCare Pharmaceuticals Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Genzyme and Bayer Schering Pharma AG, Germany Announce Start of Phase 3 Program with Alemtuzumab for Treatment of Multiple Sclerosis
2. Bayer Issues Additional Guidance to Physicians on Trasylol(R)
3. Bayer and Regeneron Dose First Patient in Second Phase 3 Study for VEGF Trap-Eye in Wet Age-Related Macular Degeneration
4. Bayer HealthCare Celebrates 20th Anniversary of Kogenate(R) Product Line and 8 Billion IU Milestone at 2008 WFH World Congress
5. Cell Therapeutics, Inc. (CTI) to Hold Conference Call to Discuss Agreement With Bayer Schering Pharma for Access to Phase III Zevalin(R) FIT Trial Data
6. Bayer and Onyx Begin Enrollment in STORM Trial Studying Nexavar as Adjuvant Therapy for Patients With Liver Cancer
7. FDA Approves Bayer HealthCares Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A
8. Bayer Announces Upcoming Presentations of Campath(R) and Leukine(R) Data at the 50th Annual Meeting of the American Society of Hematology
9. Bayer and Regeneron Extend Development Program for VEGF Trap-Eye to Include Central Retinal Vein Occlusion
10. Bayer Announces Leukine(R) Data Presentations at 45th American Society of Clinical Oncology (ASCO) Annual Meeting
11. Bayer Announces New Data on Novel Anti-cancer Compound BAY 73-4506
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... 30, 2015   Millar, Inc. , a leader ... the 2016 retirement of Craig Thummel , President/CEO ... years of service to the Company. The Company also ... members of the Executive Management team as his successors. ... , currently Director of Sales and Marketing, as President, ...
(Date:6/30/2015)... VALLEY, Pa. , June 30, 2015 /PRNewswire/ ... and delivering innovative solutions for medical and surgical ... is guaranteeing next-day replacements for surgical equipment at ... product manufacturer to offer this type of guarantee. ... Olympus Full Service Agreement earlier this year. ...
(Date:6/30/2015)... Calif. , June 30, 2015  Ardelyx, Inc. ... on cardio-renal, gastrointestinal and metabolic diseases, today announced that ... July 14, 2015, from 8:00 a.m.- 1:00 pm EDT ... The Ardelyx senior management team will present ... lead compound, tenapanor, which has completed Phase 2b clinical ...
Breaking Medicine Technology:Millar, Inc. Announces Leadership Changes 2Millar, Inc. Announces Leadership Changes 3Olympus Introduces Industry-First Next-Day Product Replacement Guarantee for Surgical Business 2Olympus Introduces Industry-First Next-Day Product Replacement Guarantee for Surgical Business 3Ardelyx to Host Inaugural R&D Investor Day in New York City on July 14, 2015 2
... The U.S. Food and Drug Administration is requiring ... on their labels about the risk of a ... systemic fibrosis (NSF), if the drug is administered ... (Logo:   http://photos.prnewswire.com/prnh/20090824/FDALOGO ) (Logo:   ...
... (Nasdaq: MSON ), a developer of ... which worldwide is used for acute health conditions, ... distribution agreement with Dismeval, s.l.,  based in Valencia, ... Ultrasonic Surgical Aspirator and the BoneScalpel™ Ultrasonic Bone ...
Cached Medicine Technology:FDA: New Warnings Required on Use of Gadolinium-Based Contrast Agents 2Misonix Announces New Distribution Agreement For Spain 2Misonix Announces New Distribution Agreement For Spain 3
(Date:6/30/2015)... ... June 30, 2015 , ... ... new video, “Grand Terrace Health Care Center.” Each year, Medicare ranks care centers ... find the best facility for their needs. Grand Terrace prides itself on quality ...
(Date:6/30/2015)... ... 2015 , ... According to a recent report by the U.S. Drug Enforcement ... than tripled in the same period—leading a majority of law enforcement agencies to cite ... leading Florida-based drug treatment facility, asserts that these heroin statistics point to an urgent ...
(Date:6/30/2015)... ... June 30, 2015 , ... ... today that they have been awarded the exclusive billing agreements with Jackson Radiology ... of billing services encompassing their proprietary suite of billing process software functionality called ...
(Date:6/30/2015)... Angeles, CA (PRWEB) , ... June 30, 2015 , ... ... You Have Acne ,” listed five triggers that most people would not expect ... hair care products, and toothpaste. The primary causes of acne are clogged ...
(Date:6/30/2015)... ... 30, 2015 , ... Lakeview Health, a drug and alcohol ... of its medical staff to further enhance its ability to treat addiction patients ... and physician assistants -- now totals 17, compared to 7 in 2013, the ...
Breaking Medicine News(10 mins):Health News:Grand Terrace Health Care Center Announces Five-Star Rating in YouTube Video 2Health News:Novus Medical Detox Center Urges Education and Action as New DEA Report Reveals Rising Heroin Use and Deaths 2Health News:Novus Medical Detox Center Urges Education and Action as New DEA Report Reveals Rising Heroin Use and Deaths 3Health News:Novus Medical Detox Center Urges Education and Action as New DEA Report Reveals Rising Heroin Use and Deaths 4Health News:ADVOCATE Wins Billing Agreements with Jackson Radiology Associates 2Health News:A List of 5 Surprising Acne Triggers and the Latest Acne Treatment Options 2Health News:Lakeview Health, a Nationally Recognized Drug Rehabilitation Center in Florida, Doubles Size of Medical Staff 2
... quality of patient care using Microsoft technology.CHICAGO, April ... and Microsoft Corp. today announced the winners of ... For more than a decade, the honors have ... systems integrators that have demonstrated significant advancements, innovation ...
... and renowned Smoking Cessation Specialist Franc Tausch achieves record success rates ... session , ... Los Angeles, CA (PRWEB) August 15, ... Angeles, California enables smokers to stop smoking for life ...
... or Hispanic, report finds , , MONDAY, April 6 (HealthDay News) ... well known, but researchers have now produced an overview of ... intermittent or occasional smokers, which the U.S. Centers for ... smokers in the country, is published in a series of ...
... that modifies the androgen receptor (AR) and influences its ability ... cancer. The research, published by Cell Press in the April ... also drive creation of new strategies for the treatment of ... therapies. , The AR is an important mediator for ...
... first four in nation to receive accreditationGREEN BAY, ... Medical Center is one of the first four ... the National Accreditation Program for Breast Centers (NAPBC), ... the first breast program in Wisconsin to earn ...
... expanding nationally OKLAHOMA CITY, April 6 ... franchise to combine practical and spiritual assistance, is opening ... Cordova, Tenn. is scheduled to open on April 8, ... services outside of Oklahoma," said Tony Vann, vice president ...
Cached Medicine News:Health News:Microsoft and Microsoft Health Users Group Announce Winners of Microsoft HUG 2009 Innovation Awards 2Health News:Microsoft and Microsoft Health Users Group Announce Winners of Microsoft HUG 2009 Innovation Awards 3Health News:Microsoft and Microsoft Health Users Group Announce Winners of Microsoft HUG 2009 Innovation Awards 4Health News:Hypnotherapy Breakthrough: Renowned Smoking Cessation Specialist Helps To Stop Smoking In One Session 2Health News:Researchers Profile the 'Light' Smoker 2Health News:A potential new target for treatment of hormone refractory prostate cancer 2Health News:Aurora BayCare is Wisconsin's First Nationally Accredited Breast Program 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: